S&P 500   5,134.80 (-0.04%)
DOW   39,001.95 (-0.22%)
QQQ   444.61 (-0.22%)
AAPL   173.92 (-3.19%)
MSFT   415.26 (-0.06%)
META   501.45 (-0.17%)
GOOGL   132.62 (-3.30%)
AMZN   178.00 (-0.12%)
TSLA   187.59 (-7.43%)
NVDA   866.28 (+5.29%)
NIO   5.35 (-7.44%)
AMD   206.59 (+1.95%)
BABA   71.89 (-3.66%)
T   16.80 (-1.06%)
F   12.85 (+3.21%)
MU   96.61 (+1.53%)
CGC   3.01 (-6.23%)
GE   160.55 (+1.20%)
DIS   113.60 (+1.47%)
AMC   4.29 (-1.61%)
PFE   25.79 (-3.01%)
PYPL   59.67 (-1.44%)
XOM   104.47 (-1.29%)
S&P 500   5,134.80 (-0.04%)
DOW   39,001.95 (-0.22%)
QQQ   444.61 (-0.22%)
AAPL   173.92 (-3.19%)
MSFT   415.26 (-0.06%)
META   501.45 (-0.17%)
GOOGL   132.62 (-3.30%)
AMZN   178.00 (-0.12%)
TSLA   187.59 (-7.43%)
NVDA   866.28 (+5.29%)
NIO   5.35 (-7.44%)
AMD   206.59 (+1.95%)
BABA   71.89 (-3.66%)
T   16.80 (-1.06%)
F   12.85 (+3.21%)
MU   96.61 (+1.53%)
CGC   3.01 (-6.23%)
GE   160.55 (+1.20%)
DIS   113.60 (+1.47%)
AMC   4.29 (-1.61%)
PFE   25.79 (-3.01%)
PYPL   59.67 (-1.44%)
XOM   104.47 (-1.29%)
S&P 500   5,134.80 (-0.04%)
DOW   39,001.95 (-0.22%)
QQQ   444.61 (-0.22%)
AAPL   173.92 (-3.19%)
MSFT   415.26 (-0.06%)
META   501.45 (-0.17%)
GOOGL   132.62 (-3.30%)
AMZN   178.00 (-0.12%)
TSLA   187.59 (-7.43%)
NVDA   866.28 (+5.29%)
NIO   5.35 (-7.44%)
AMD   206.59 (+1.95%)
BABA   71.89 (-3.66%)
T   16.80 (-1.06%)
F   12.85 (+3.21%)
MU   96.61 (+1.53%)
CGC   3.01 (-6.23%)
GE   160.55 (+1.20%)
DIS   113.60 (+1.47%)
AMC   4.29 (-1.61%)
PFE   25.79 (-3.01%)
PYPL   59.67 (-1.44%)
XOM   104.47 (-1.29%)
S&P 500   5,134.80 (-0.04%)
DOW   39,001.95 (-0.22%)
QQQ   444.61 (-0.22%)
AAPL   173.92 (-3.19%)
MSFT   415.26 (-0.06%)
META   501.45 (-0.17%)
GOOGL   132.62 (-3.30%)
AMZN   178.00 (-0.12%)
TSLA   187.59 (-7.43%)
NVDA   866.28 (+5.29%)
NIO   5.35 (-7.44%)
AMD   206.59 (+1.95%)
BABA   71.89 (-3.66%)
T   16.80 (-1.06%)
F   12.85 (+3.21%)
MU   96.61 (+1.53%)
CGC   3.01 (-6.23%)
GE   160.55 (+1.20%)
DIS   113.60 (+1.47%)
AMC   4.29 (-1.61%)
PFE   25.79 (-3.01%)
PYPL   59.67 (-1.44%)
XOM   104.47 (-1.29%)

Iterum Therapeutics (ITRM) Insider Trading & Ownership

$1.27
-0.03 (-2.35%)
(As of 01:24 PM ET)

Iterum Therapeutics (NASDAQ:ITRM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.40%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$91,500.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get ITRM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ITRM Insider Buying and Selling by Quarter


Iterum Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/22/2023Michael W DunneDirectorBuy25,000$1.40$35,000.00  
11/22/2023Michael W DunneDirectorBuy20,000$2.03$40,600.00  
11/20/2023Corey N FishmanCEOBuy10,000$1.59$15,900.00  
(Data available from 1/1/2013 forward)












ITRM Insider Trading Activity - Frequently Asked Questions

Who is on Iterum Therapeutics's Insider Roster?

The list of insiders at Iterum Therapeutics includes Brenton Karl Ahrens, Corey N Fishman, Judith M Matthews, Michael W Dunne, and Sailaja Puttagunta. Learn more on insiders at ITRM.

What percentage of Iterum Therapeutics stock is owned by insiders?

5.40% of Iterum Therapeutics stock is owned by insiders. Learn more on ITRM's insider holdings.

Which Iterum Therapeutics insiders have been buying company stock?

The following insiders have purchased ITRM shares in the last 24 months: Corey N Fishman ($15,900.00), and Michael W Dunne ($97,800.00).

How much insider buying is happening at Iterum Therapeutics?

Insiders have purchased a total of 65,000 ITRM shares in the last 24 months for a total of $113,700.00 bought.

Which Iterum Therapeutics insiders have been selling company stock?

The following insiders have sold ITRM shares in the last 24 months: Brenton Karl Ahrens ($156,000.00), Judith M Matthews ($17,910.16), and Sailaja Puttagunta ($4,441.80).

How much insider selling is happening at Iterum Therapeutics?

Insiders have sold a total of 125,497 Iterum Therapeutics shares in the last 24 months for a total of $178,351.96 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ITRM) was last updated on 3/4/2024 by MarketBeat.com Staff